What is the pathogenesis, typical clinical manifestations, and characteristic nail findings of psoriasis in a 44-year-old white woman with a 2-year history of the disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Psoriasis: Pathogenesis, Clinical Manifestations, and Nail Findings

Underlying Cause of Psoriasis

Psoriasis is a genetic, systemic, inflammatory, chronic disorder driven by inappropriate activation of cutaneous T cells and dendritic cells, leading to excessive cytokine release (particularly IL-23 and IL-17) that causes keratinocyte hyperproliferation and chronic inflammation. 1, 2 The disease can be modified by environmental factors and has strong genetic susceptibility, as evidenced by your patient's family history of psoriasis 1.

The pathogenesis involves:

  • Immune dysregulation: Overactivation of T cells and dendritic cells in the skin
  • Cytokine cascade: Release of inflammatory mediators (IL-23, IL-17, TNF-alpha) that perpetuate inflammation
  • Keratinocyte hyperproliferation: Rapid skin cell turnover manifesting as characteristic plaques
  • Genetic predisposition: Multiple susceptibility loci identified, including chromosome 16 regions 1

This is fundamentally a multisystem inflammatory disease, not just a skin condition—it affects approximately 2% of the population and is associated with significant systemic comorbidities 1, 2.

Common Signs and Symptoms

The hallmark presentation is well-demarcated, erythematous (red) plaques with silvery scale, accompanied by pruritus (itching) and often pain. 1, 2

Primary Cutaneous Features:

  • Plaque-type psoriasis (most common): Thick, raised, red plaques with silvery-white scale
  • Distribution: Scalp, elbows, knees, presacral region most commonly affected, though any skin area can be involved including palms, soles, and genitalia 2
  • Pruritus: Often severe and significantly impacts quality of life 1
  • Scaling: Characteristic silvery scale that distinguishes psoriasis from other inflammatory conditions

Clinical Variants Your Patient May Exhibit:

  • Guttate: Small (1-10mm) salmon-pink papules with fine scale, more common in younger patients (<30 years) 1
  • Inverse: Erythematous plaques with minimal scale in skin folds (axillary, genital, inframammary areas) 1
  • Pustular: Visible pustules on erythematous background (less common but severe) 1
  • Erythrodermic: Generalized erythema with systemic symptoms like fever and malaise (rare but serious) 1

Important Quality of Life Impact:

The disease causes disfiguring, scaling, and erythematous plaques that may be painful or severely pruritic and cause significant quality of life issues 1. It is a chronic disease that waxes and wanes throughout a patient's lifetime with few spontaneous remissions 1.

Characteristic Nail Findings on Inspection and Palpation

The four cardinal nail findings in psoriasis are: (1) pitting, (2) onycholysis, (3) subungual hyperkeratosis, and (4) oil-drop sign (salmon patches). 1

Prevalence and Clinical Significance:

  • Fingernails affected in approximately 50% of all psoriasis patients
  • Toenails affected in 35% of patients 1
  • Up to 90% of patients with psoriatic arthritis have nail changes, making nail examination critical for identifying joint disease risk 1

Specific Nail Findings by Anatomical Location:

Nail Matrix Involvement:

  • Pitting: Small depressions in the nail plate (most common finding, seen in 62.2% of nail psoriasis cases) 3
  • Leukonychia: White discoloration of the nail
  • Red spots in the lunula: Visible in the half-moon area
  • Crumbling: Severe nail dystrophy with matrix destruction 4

Nail Bed Involvement:

  • Onycholysis: Separation of the nail plate from the nail bed (most common overall finding, present in 80-93.3% of cases) 5, 3
  • Subungual hyperkeratosis: Thickening under the nail plate (75.5-80% of cases) 5, 3
  • Oil-drop sign (salmon patches): Yellow-brown discoloration resembling an oil drop under the nail 1
  • Splinter hemorrhages: Linear red-brown streaks under the nail 6

On Palpation:

  • Nails may feel thickened and rough
  • Subungual hyperkeratosis creates palpable elevation
  • In trachyonychia variant, nail surface feels characteristically rough 7

Clinical Pearls and Pitfalls:

Critical Association: Nail psoriasis severity correlates strongly with:

  • Duration of disease (P < 0.001) 3
  • Skin disease severity (PASI scores, P < 0.001) 3
  • Risk of psoriatic arthritis development (P < 0.05) 3

Common Pitfall: Always consider onychomycosis as a differential diagnosis or coexisting condition—fungal elements were found in 26% of nail psoriasis cases in one study 5. When in doubt, perform PAS staining or fungal culture.

Therapeutic Challenge: Nail psoriasis is recognized as a significant therapeutic challenge and often requires more aggressive systemic therapy rather than topical treatments alone 1.

Examination Approach:

Systematically examine all 20 nails (fingernails and toenails) for:

  1. Surface changes: Pitting, roughness, crumbling
  2. Color changes: Oil-drop sign, leukonychia, splinter hemorrhages
  3. Structural changes: Onycholysis, subungual hyperkeratosis
  4. Nail fold: Look for psoriatic paronychia 6

Given your patient's 2-year history and worsening symptoms, thorough nail examination is essential as nail involvement may indicate need for systemic therapy and increased vigilance for psoriatic arthritis development.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.